Therapeutic effects of paeoniflorin on irritable bowel syndrome in rats

被引:3
|
作者
Wang, Lei [1 ,2 ]
Lei, Jinyan [2 ,3 ]
Zhao, Zeyu [4 ]
Jia, Jianwei [2 ,3 ]
Wang, Li [1 ,5 ]
机构
[1] Tianjin Second Peoples Hosp, Dept Pharm, Tianjin 300192, Peoples R China
[2] Tianjin Inst Hepatol, Tianjin 300192, Peoples R China
[3] Tianjin Second Peoples Hosp, Dept Integrated Chinese & Western Med, Tianjin 300192, Peoples R China
[4] Tianjin Univ Tradit Chinese Med, Sch Integrat Med, Tianjin 301600, Peoples R China
[5] Tianjin Univ, Acad Med Engn & Transnat Med, Tianjin 300072, Peoples R China
关键词
Colon; intestinal flora; sequence analysis; RNA; enzyme-linked immunosorbent assay; abdominal pain; MOLECULAR ANALYSIS; MICROBIOTA; PROBIOTICS; MUCIN;
D O I
10.4142/jvs.22083
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background: Irritable bowel syndrome (IBS) is a functional bowel disorder (FBD). Objectives: To assess the therapeutic effects of paeoniflorin (PF) on IBS in rats. Method: Sixty male Sprague-Dawley rats were randomly divided into normal, model, positive drug, low-dose PF, medium-dose PF and high- dose PF groups (n = 10). After gavage for 2 consecutive weeks, the effect of PF on abdominal pain symptoms was assessed based on the abdominal withdrawal reflex (AWR) score, fecal water content and pathological changes in colon tissues. D-lactate, interleukin-1 beta (IL-1 beta), transforming growth factor-beta (TGF-beta) and tumor necrosis factor-alpha (TNF-alpha) were detected by enzyme-linked immunosorbent assay, and phosphorylated nuclear factor kappa B (p-NF-kappa B) p65 was detected by Western blotting. The abundance and diversity changes of intestinal flora were explored using 16S ribosomal RNA sequencing. Result: In PF groups, the mucosal morphology of colon tissues was intact, and the glands were arranged neatly and structured clearly, without obvious inflammatory cell infiltration. Compared with the model group, PF groups had significantly elevated pain threshold, and mRNA and protein levels of zonula occludens-1 (ZO-1) and occludin, decreased AWR score at 20 mmHg pressure, fecal water content, mRNA levels of IL-1 beta, TGF-beta, and TNF-alpha, protein level of p-NF-kappa B p65 and level of serum D-lactate, and reduced levels of serum IL-1 beta, TGF-beta, and TNF-alpha (p < 0.05, p < 0.01). PF groups had higher abundance of Lactobacillus, Akkermansia, Alistipes, and Bacteroides, but lower abundance of Desulfovibrio, Parasutterella, and Enterococcus than those of the model group. Conclusions: PF exerts therapeutic effects on IBS in rats probably by regulating the intestinal flora, and then up-regulating the expressions of ZO-1 and occludin in colon tissue while down-regulating the levels of IL-1 beta, TGF-beta, TNF-alpha, D-lactate and p-NF-kappa B p65.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Paeoniflorin Ameliorates Colonic Fibrosis in Rats with Postinfectious Irritable Bowel Syndrome by Inhibiting the Leptin/LepRb Pathway
    Tian, Ya-Qing
    Zhang, Sheng-Peng
    Zhang, Kun-Li
    Cao, Di
    Zheng, Yi-Jun
    Liu, Ping
    Zhou, Hui-Hui
    Wu, Ya-Ning
    Xu, Qi-Xiang
    Liu, Xiao-Ping
    Tang, Xu-Dong
    Zheng, Yong-Qiu
    Wang, Feng-Yun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [2] Paeoniflorin Ameliorates Colonic Fibrosis in Rats with Postinfectious Irritable Bowel Syndrome by Inhibiting the Leptin/LepRb Pathway
    Tian, Ya-Qing
    Zhang, Sheng-Peng
    Zhang, Kun-Li
    Cao, Di
    Zheng, Yi-Jun
    Liu, Ping
    Zhou, Hui-Hui
    Wu, Ya-Ning
    Xu, Qi-Xiang
    Liu, Xiao-Ping
    Tang, Xu-Dong
    Zheng, Yong-Qiu
    Wang, Feng-Yun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [3] Hypnosis for irritable bowel syndrome: The empirical evidence of therapeutic effects
    Whitehead, WE
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL HYPNOSIS, 2006, 54 (01) : 7 - 20
  • [4] Therapeutic strategy in irritable bowel syndrome
    Piessevaux, H
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2001, 64 (03) : 281 - 285
  • [5] Effects of Intestinal Flora on Irritable Bowel Syndrome and Therapeutic Significance of Polysaccharides
    Ye, Yang
    Liu, Yanan
    Cheng, Kejun
    Wu, Zufang
    Zhang, Peng
    Zhang, Xin
    FRONTIERS IN NUTRITION, 2022, 9
  • [6] Update in the therapeutic management of irritable bowel syndrome
    Villanueva, A
    Domínguez-Muñoz, JE
    Mearin, F
    DIGESTIVE DISEASES, 2001, 19 (03) : 244 - 250
  • [7] THERAPEUTIC STRATEGY FOR THE IRRITABLE-BOWEL-SYNDROME
    CASTIGLIONE, F
    DANIELE, B
    MAZZACCA, G
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1991, 23 (08): : 53 - 55
  • [8] New therapeutic approaches in irritable bowel syndrome
    Camilleri, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2008, 12 : 139 - 140
  • [9] THERAPEUTIC STRATEGY IN THE IRRITABLE-BOWEL-SYNDROME
    THOMPSON, WG
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1990, 14 (5BIS): : C74 - C80
  • [10] Irritable bowel syndrome: an update on therapeutic modalities
    Farhadi, A
    Bruninga, K
    Fields, J
    Keshavarzian, A
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (07) : 1211 - 1222